Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-79.67	19.47	95.75
Graham Fair Price	inf	0.00	24.83
PEG	inf	0.00	-0.06
Price/Book	inf	0.00	-0.49
Price/Cash Flow	inf	0.00	-6.84
Prices/Earnings	inf	0.00	-1.64
Price/Sales	inf	0.00	0.85
Price/FCF	inf	0.00	-6.84
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.12	0.24	0.24
Operating Margin	6.73	< 0.005	< 0.005
ROA	-451.62	-0.20	-0.04
ROE	0.08	0.32	322.74
ROIC	< 0.005	< 0.005	19.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.53	0.02	2915.51
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.19	-2.15	80.75
EPS QOQ	0.29	1.00	242.37
FCF QOQ	-2.34	-1.36	41.95
Revenue QOQ	-0.11	0.07	-34.63
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	88.71	83.71	-5.63
Days Sales Outstanding (DSO)	266.74	259.60	-2.68
Inventory Turnover	1.01	1.08	5.97
Debt/Capitalization	2.27	-1.43	-37.02
Quick Ratio	0.51	0.39	-23.40
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	-19.11	0.00	inf
Cash	3.38	0.00	inf
Capex	-0.14	0.00	inf
Free Cash Flow	-1.38	0.00	inf
Revenue	11.04	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.04	0.69	-33.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	73.45	19.47	-73.49
Naive Interpretation	Member

06 - Financial Health · Bad

Rating